Wednesday, July 29, 2020

India#39;s Hetero Labs wins approval to launch COVID-19 drug favipiravir

India#39;s Hetero Labs wins approval to launch COVID-19 drug favipiravir The drug, priced at 59 rupees (79 cents) per tablet, will be available at drug stores from Wednesday, privately held Hetero said.

from Moneycontrol Business News https://ift.tt/2Dfe7Pg

No comments:

Post a Comment

Equitas Small Finance Bank chief PN Vasudevan plans exit over perceived conflict involving daughter's NBFC

PN Vasudevan's recent announcement of his resignation as managing director of Equitas Small Finance Bank highlights pressing concerns ov...